Literature DB >> 17442746

Homozygous SCN5A mutation in Brugada syndrome with monomorphic ventricular tachycardia and structural heart abnormalities.

Gianfranco Frigo1, Alessandra Rampazzo, Barbara Bauce, Kalliopi Pilichou, Giorgia Beffagna, Gian Antonio Danieli, Andrea Nava, Bortolo Martini.   

Abstract

AIMS: To describe a patient showing monomorphic ventricular tachycardia, ECG aspect of Brugada syndrome, and structural heart abnormalities due to a homozygous missense mutation in SCN5A. METHODS AND
RESULTS: Thirteen subjects (six males, seven females, mean age 46 +/- 22 years) belonging to the same family underwent physical examination, basal biochemical marker detection, 12-lead ECG, Holter ECG, signal-averaged ECG, echocardiogram and genetic analysis. The proband underwent a stress test together with left and right ventricular angiography and electrophysiological study. Three subjects (the proband, his mother, and one brother) showed on ECG an ST-segment elevation in the right precordial leads with coved type aspect. Moreover, the proband presented a sustained monomorphic ventricular tachycardia (left bundle branch block aspect with superior axis), whereas all other family members were asymptomatic. Imaging techniques documented right ventricular structural abnormalities only in the proband. Mutation screening in SCN5A gene was performed in the proband and in available family members. The proband carries a novel SCN5A mutation, R814Q, in homozygous, whereas the parents and four siblings were heterozygous carriers of the same mutation.
CONCLUSION: This study provides the first evidence of a homozygous missense mutation in SCN5A associated with atypical ventricular arrhythmias and right structural abnormalities.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17442746     DOI: 10.1093/europace/eum053

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  15 in total

1.  Striking In vivo phenotype of a disease-associated human SCN5A mutation producing minimal changes in vitro.

Authors:  Hiroshi Watanabe; Tao Yang; Dina Myers Stroud; John S Lowe; Louise Harris; Thomas C Atack; Dao W Wang; Susan B Hipkens; Brenda Leake; Lynn Hall; Sabina Kupershmidt; Nagesh Chopra; Mark A Magnuson; Naohito Tanabe; Björn C Knollmann; Alfred L George; Dan M Roden
Journal:  Circulation       Date:  2011-08-08       Impact factor: 29.690

2.  High-Throughput Reclassification of SCN5A Variants.

Authors:  Andrew M Glazer; Yuko Wada; Bian Li; Ayesha Muhammad; Olivia R Kalash; Matthew J O'Neill; Tiffany Shields; Lynn Hall; Laura Short; Marcia A Blair; Brett M Kroncke; John A Capra; Dan M Roden
Journal:  Am J Hum Genet       Date:  2020-06-12       Impact factor: 11.025

3.  Disease variant prediction with deep generative models of evolutionary data.

Authors:  Jonathan Frazer; Pascal Notin; Mafalda Dias; Aidan Gomez; Joseph K Min; Kelly Brock; Yarin Gal; Debora S Marks
Journal:  Nature       Date:  2021-10-27       Impact factor: 49.962

Review 4.  The cardiac sodium channel gene SCN5A and its gene product NaV1.5: Role in physiology and pathophysiology.

Authors:  Christiaan C Veerman; Arthur A M Wilde; Elisabeth M Lodder
Journal:  Gene       Date:  2015-09-08       Impact factor: 3.688

5.  A novel NaV1.5 voltage sensor mutation associated with severe atrial and ventricular arrhythmias.

Authors:  Hong-Gang Wang; Wandi Zhu; Ronald J Kanter; Jonathan R Silva; Christina Honeywell; Robert M Gow; Geoffrey S Pitt
Journal:  J Mol Cell Cardiol       Date:  2016-01-19       Impact factor: 5.000

6.  Nav 1.5 mutations linked to dilated cardiomyopathy phenotypes: Is the gating pore current the missing link?

Authors:  Pascal Gosselin-Badaroudine; Adrien Moreau; Mohamed Chahine
Journal:  Channels (Austin)       Date:  2013-12-03       Impact factor: 2.581

7.  Pathophysiological role of omega pore current in channelopathies.

Authors:  Karin Jurkat-Rott; James Groome; Frank Lehmann-Horn
Journal:  Front Pharmacol       Date:  2012-06-11       Impact factor: 5.810

8.  Deletion of PDK1 causes cardiac sodium current reduction in mice.

Authors:  Zhonglin Han; Yu Jiang; Yuqing Yang; Xuehan Li; Zhongzhou Yang; Kejiang Cao; Dao W Wang
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

Review 9.  Biophysics, pathophysiology, and pharmacology of ion channel gating pores.

Authors:  Adrien Moreau; Pascal Gosselin-Badaroudine; Mohamed Chahine
Journal:  Front Pharmacol       Date:  2014-04-03       Impact factor: 5.810

Review 10.  The electrocardiographic manifestations of arrhythmogenic right ventricular dysplasia.

Authors:  Li Zhang; Liwen Liu; Peter R Kowey; Guy H Fontaine
Journal:  Curr Cardiol Rev       Date:  2014-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.